Lataa...

The Discovery and Development of Daclatasvir: An Inhibitor of the Hepatitis C Virus NS5A Replication Complex

The discovery of the hepatitis C virus (HCV) NS5A replication inhibitor daclatasvir (1) had its origins in a phenotypic screening lead. However, during the optimization campaign, it was observed that some members of the chemotype underwent a radical dimerization under the assay conditions. This redi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:HCV: The Journey from Discovery to a Cure
Päätekijät: Meanwell, Nicholas A., Belema, Makonen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7122418/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/7355_2018_47
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!